Pharmaceutical Supply Chain Security Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Pharmaceutical Supply Chain Security Act
This bill directs certain agencies to report on and reduce the role of China in pharmaceutical supply chains.
Specifically, the Food and Drug Administration must report on pharmaceutical products and ingredients for which China supplies more than 20% of the quantities available in the United States. In addition, the President must develop a strategy to address the role of China in the global pharmaceutical supply chain and related threats to national security. The United States International Development Finance Corporation must also support manufacturing projects that promote the security of pharmaceutical supply chains, reduce reliance on China, and foster cooperation with other countries.
Read twice and referred to the Committee on Foreign Relations.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 2454: Pharmaceutical Supply Chain Security Act. 118th Congress. Open America. https://openamerica.io/bill/118-S-2454/
"S. 2454: Pharmaceutical Supply Chain Security Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-2454/.
S. 2454, 118th Cong. (2026), https://openamerica.io/bill/118-S-2454/.
[S. 2454: Pharmaceutical Supply Chain Security Act](https://openamerica.io/bill/118-S-2454/)